Novavax’s protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low
admin U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read Moreremains
Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low
U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreChina’s commodities imports might be close to a bottom, but demand remains soft, says economist
China saw a sharp slowdown in its commodities imports in June as the economy saw…
Read More